Literature DB >> 402376

Graves' disease associated with familial deficiency of thyroxine-binding globulin.

D L Horwitz, S Refetoff.   

Abstract

Five patients presented with symptoms of Graves' disease and a marked decrease in their thyroxine-binding globulin (TBG) capacity. While thyrotoxic, mean values +/- SD for the 5 patients were: total thyroxine (TT4) 8.8+/-2.0 mug/100 ml (normal range 4.4-9.3); TBG capacity 6.1+/-1.1 mug T4/100 ml (normal range 16-24); free thyroxine index (FTI) 25.3+/-8.9 (normal range 3.6-9.3); and total triiodo-thyronine (TT3) 244+/-56 ng/100 ml (normal range 80-160). When euthyroid, both TT4 (2.8+/-0.8 mug/100 ml) and TT3 (68+/-12 ng/100 ml) were below the normal range and FTI (5.8+/-0.6) was normal. All patients were male, and family studies revealed decreased TBG capacity in blood relatives consistent with X-chromosome linked inheritance. All examined relatives relatives of the propositi, whether hemizygous or heterozygous, were euthyroid. Over the same period of time 7 additional patients (excluding family members of propositi) were found to be euthyroid but had decreased TBG capacity. The occurrence of thyrotoxicosis in 5 out of 12 patients with inherited TBG deficiency suggests an association rather than a coincidental finding, although initial tests were performed because of suspected thyroid dysfunction. The incidence of thyrotoxicosis in patients with inherited TBG deficiency is also high on the basis of the reported prevalence of the latter genetic abnormality. This study stresses the importance of determining TT3 and FTI on patients who are clinically thyrotoxic but have normal TT4.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402376     DOI: 10.1210/jcem-44-2-242

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Clinical recognition and evaluation of patients with inherited serum thyroid hormone-binding protein mutations.

Authors:  M S Mimoto; S Refetoff
Journal:  J Endocrinol Invest       Date:  2019-07-27       Impact factor: 4.256

2.  Familial abnormalities of thyroxine binding proteins: some problems of recognition and interpretation.

Authors:  J E Neild; P G Byfield; M R Lalloz; D Tait; J H Marigold; D N Croft; B M Slavin
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

Review 3.  Studies on thyroxine-binding globulin.

Authors:  L Bartalena
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

4.  A NOVEL MUTATION CAUSING COMPLETE THYROID BINDING GLOBULIN DEFICIENCY (TBG-CD MIA) IN A MALE WITH COEXISTING GRAVES DISEASE.

Authors:  Hara Rosen Berger; Matthew K Creech; Zeina Hannoush; Yui Watanabe; Atil Kargi; Roy E Weiss
Journal:  AACE Clin Case Rep       Date:  2017

5.  Two new inherited defects of the thyroxine-binding globulin (TBG) molecule presenting as partial TBG deficiency.

Authors:  J Takamatsu; S Refetoff; M Charbonneau; J H Dussault
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

6.  Preliminary evidence of a noncausal association between the X-chromosome inactivation pattern and thyroid autoimmunity: a twin study.

Authors:  Thomas Heiberg Brix; Pia Skov Hansen; Kirsten Ohm Kyvik; Laszlo Hegedüs
Journal:  Eur J Hum Genet       Date:  2009-09-30       Impact factor: 4.246

7.  Inherited X chromosome linked thyroxine-binding globulin (TBG) deficiency in a homozygous female.

Authors:  M Bigazzi; R Ronga; A L Olivotti; G Scarselli; S Refetoff
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

8.  Familial thyroxine-binding globulin deficiency detected in a pilot screening program for congenital hypothyroidism.

Authors:  M Carta Sorcini; L Moschini; L Fiore; S Tomarchio; M G Di Irio; E Gilardi; C Romagnoli; V Currò; S Carta
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

9.  Hyperthyroidism with normal serum total T4, T3, and thyroid binding protein concentration.

Authors:  J F Caro; N G Sloane; J A Glennon
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.